The development of animal models for Graves’ disease were accelerated with the sequencing of the TSHR and consequently the availability of recombinant TSHR DNA, which made it amenable to prepare substantial quantities of recombinant TSHR protein or synthetic peptides for active immunization. Here, TSHR is linked to Graves disease.